CLOSE

Benchmark Investments

Quant Healthcare Fund-Reg(G)

very highequitypharma & health care
14.54 -0.07(-0.50%) NAV as on 02 May 2025
3.1 % 1 M
4.97 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

2.39

As on 30 Apr, 2025
Age :

1 yrs 9 m

Since 17 07 ,2023
Exit Load :

1%

AUM :

369.93 Crs

Portfolio Price To Book Value :

5.83

Investing Style :

Large Growth

Min. Investment :

SIP 1000 & Lumpsum 5000

Category :

sector funds

Fund Manager :

Sandeep Tandon,Ankit Pande,Varun Pattani

Launch Date :

17-Jul-23

Scheme Benchmark :

NA

FUND OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2025
Others -0.33 %
Debt 2.69 %
Equity 97.64 %

TOP HOLDINGS

Divi's Laboratories Ltd.9.57 %
RPG Life Sciences Ltd.9.28 %
Aster DM Healthcare Ltd.9.22 %
Ipca Laboratories Ltd.7.42 %
Torrent Pharmaceuticals Ltd.7.31 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs68.41
Hospital & Healthcare Services11.60
Refineries6.69
Consumer Food5.83
Telecom-Infrastructure5.11
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-2025
NAV in Rs (as on 31-Mar-2025)13.1214.10
Net Assets(Rs Crores) (as on 31-Mar-2025) 264.51 369.93
Scheme Returns(%)(Absolute)31.205.12
B'mark Returns(%)(Absolute)NANA
Category Rank54/9058/102

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2024-202511.8216.81-7.88-10.71
2023-2024NANA13.487.78

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Quant Healthcare Fund-Reg(G)Very HighEquity14.54-0.07(-0.50%)NAV As on 02 May, 202517-Jul-2023Inception Date369.93AUM In Cr.4.97%1YNA%3YNA%5Y23.19%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.11-0.22(-0.59%)NAV As on 02 May, 202513-Jul-2018Inception Date4,914.64AUM In Cr.20.60%1Y24.15%3Y25.12%5Y21.24%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity420.10-0.14(-0.03%)NAV As on 02 May, 202514-Jul-1999Inception Date3,610.51AUM In Cr.21.24%1Y23.79%3Y24.67%5Y16.32%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.21-0.14(-0.47%)NAV As on 02 May, 202528-Dec-2015Inception Date1,183.65AUM In Cr.15.57%1Y20.31%3Y21.88%5Y12.15%Since Inception
Nippon India Pharma Fund(G)Very HighEquity493.65-3.32(-0.67%)NAV As on 02 May, 202505-Jun-2004Inception Date8,080.97AUM In Cr.14.84%1Y20.01%3Y22.36%5Y20.49%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd